Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
CALC
#4865
CalciMedica, Inc. Common Stock
0.6
4
USD
+3.23%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+3.23%
Aylık Değişim
-25.58%
6 aylık değişim
-79.94%
Yıllık Değişim
-59.75%
Önceki Kapanış
0.6
2
Open
0.6
3
Bid
Ask
Low
0.6
2
High
0.6
4
Hacim
28
Piyasalar
ABD Borsası
Sağlık Hizmetleri
CALC
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
13.48 M
13.97 M
13.97 M
14.26 M
15.74 M
—
Valuation ratios
Enterprise value
39.79 M
14.13 M
16.44 M
—
92.23 M
—
Price to earnings ratio
-2.9
-1.2
-0.98
-1.86
-3.35
-7.39
Price to sales ratio
—
—
—
—
138.74
—
Price to cash flow ratio
-1.88
-1.05
-0.97
-1.99
-4.67
-8.68
Price to book ratio
2.76
0.47
0.49
1.26
-14.9
-12.68
Enterprise value to EBITDA ratio
—
—
—
—
-4.06
—
Profitability ratios
Return on assets %
-0.22
-0.2
-0.31
-0.52
-0.79
-1.83
Return on equity %
-0.3
-0.46
-0.98
29.12
1.62
29.3
Return on invested capital %
-2 593.28
-3 244.44
-3 917.75
-2 623.7
-1 006.98
-10.79 K
Gross margin %
—
100
100
100
100
400
Operating margin %
—
-3 216.34
-3 009.55
-4 012.86
-2 903.97
-13.14 K
EBITDA margin %
—
-3 161.39
-2 954.09
-3 967.86
-2 825.83
-12.91 K
Net margin %
—
-2 496.04
-2 707.27
-5 574.29
-7 125.83
-17.9 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.34
5.66
5.45
4.04
3.58
18.72
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0.01
0.01
0.01
0.01
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.44
-0.35
-0.44
-0.32
-0.32
-1.43
EBIT per share
—
-0.45
-0.43
-0.36
-0.28
-1.52
EBITDA per share
—
-0.45
-0.43
-0.37
-0.28
-1.54
Total debt per share
—
—
—
—
—
—
Cash per share
1.66
1.74
1.2
0.94
0.87
4.74
Net current asset value per share
1.75
1.79
1.26
0.99
0.9
4.94
Tangible book value per share
1.28
0.77
0.41
-0.02
-0.44
0.72
Working capital per share
1.42
1.47
1.03
0.74
0.65
3.89
Book value per share
1.28
0.77
0.41
-0.02
-0.44
0.72
Haberler
CalciMedica’ya Nasdaq’tan iki uyarı birden
H.C. Wainwright, klinik deneme durdurmasının ardından CalciMedica hissesini Nötr’e düşürdü
CalciMedica stock downgraded to Neutral by H.C. Wainwright after trial halt
CalciMedica, Faz 2 KOURAGE denemesini komitenin tavsiyesi üzerine durdurdu
CalciMedica discontinues Phase 2 KOURAGE trial following committee recommendation
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.02%
CalciMedica hisseleri böbrek hasarı denemesinin durdurulmasının ardından düşüşte
CalciMedica, güvenlik endişeleri nedeniyle AKI denemesini durdurdu
CalciMedica discontinues AKI trial following safety concerns
CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis - CalciMedica (NASDAQ:CALC)
Oppenheimer reiterates Outperform rating on CalciMedica stock ahead of key trial
CalciMedica partners with Telperian to use AI for clinical trial analysis